Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Genotype Stratified Pharmacokinetic Study of Montelukast [Phase 1]
Phase 1 pharmacokinetic study of montelukast in asthma patients with genotype stratification completed.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
This clinical trial update describes an investigation of spirometric outcomes after bronchial thermoplasty in adults with severe asthma; the…
-
CLINICAL_TRIALS withdrawal · 2025-02-10Clinical Trial Update: Withdrawal of Dupilumab in Severe Asthma [Phase 4]
The Phase 4 trial of dupilumab for severe asthma is being withdrawn and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Transporter Mediated Uptake of Montelukast [NA]
A completed clinical trial evaluating transporter-mediated uptake of montelukast in asthma patients.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs [Phase 4]
A Phase 4 clinical trial compares emergency spacers with traditional spacers for delivering aerosolized medications via metered-dose inhaler…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Residual Exacerbations With Mepolizumab
A Laval University–sponsored study is evaluating residual exacerbations in asthma patients treated with mepolizumab and is currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Asthma In-Home Monitoring (AIM) Trial [NA]
The Asthma In-Home Monitoring (AIM) trial sponsored by Tripler Army Medical Center has completed. The trial enrolled individuals with mild t…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: LungVITamin D and OmegA-3 Trial (lungVITAL) [NA]
ClinicalTrials.gov entry for the LungVITAL trial evaluating Vitamin D and Omega-3 supplementation for COPD and asthma; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Financial Incentives to Improve Asthma [NA]
A completed clinical trial by Imperial College London assessed whether financial incentives improve adherence to asthma medications in child…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD [NA]
Completed clinical trial evaluating combined neuromuscular electrical stimulation of the quadriceps and triceps during pulmonary rehabilitat…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Exploring the Lived Experience of Young Adults With Severe Asthma
This entry notes ongoing recruitment for a study examining the lived experience of young adults with severe asthma.
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: Nutrition for Asthmatics with Obesity [NA]
A completed clinical trial evaluating a nutritional intervention for individuals with asthma and obesity.
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Childhood Asthma Management in Primary Care: Implementation Of Exhaled Nitric Oxide and Spirometry Testing
A completed clinical trial assessing the implementation of exhaled nitric oxide measurements and spirometry in primary care for managing chi…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Rural Home Hospital: Proof of Concept [NA]
Completed clinical trial update for Rural Home Hospital: Proof of Concept with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Indoor Air Quality for Black Adults With Uncontrolled Asthma
A completed study evaluating indoor air quality factors for Black adults with uncontrolled asthma, sponsored by Columbia University.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Viral Mucosal Reprogramming [Phase 2]
Phase 2 clinical trial evaluating viral mucosal reprogramming for asthma and allergic rhinitis is currently recruiting. The study is sponsor…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Study of GSK3511294 in Healthy Chinese Participants [Phase 1]
Phase 1 trial of GSK3511294 in healthy Chinese participants completed to evaluate safety and pharmacokinetics for asthma.
-
CLINICAL_TRIALS research · 2025-01-27Clinical Trial Update: A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma [Phase 2]
A Phase 2 clinical trial update for SHR-1905 in subjects with severe uncontrolled asthma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients [Phase 4]
A Phase 4 exploratory study sponsored by AstraZeneca in adult asthma patients to characterize airway inflammation, symptoms, lung function a…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: The Effect of Buteyko Breathing Technique on Asthma Control and Quality of Life in Children With Asthma [NA]
A completed clinical trial evaluating the impact of the Buteyko Breathing Technique on asthma control and quality of life in children.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Clinical Study of Lung-benefiting Moxibustion Reduce Exacerbations of Asthma [NA]
Clinical study investigating whether lung-benefiting moxibustion can reduce exacerbations in asthma; currently NOT_YET_RECRUITING.
-
FDA approval · 2025-01-14FDA Approved: IPRATROPIUM BROMIDE — Original Application (Advagen Pharma Ltd)
FDA approves an original application for ipratropium bromide from Advagen Pharma Ltd (ANDA 219222).
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma
This document reports a clinical trial evaluating the combination of omalizumab and allergen immunotherapy for allergic asthma, with the stu…
-
FDA approval · 2025-01-13FDA Approved: THEOPHYLLINE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA's Theophylline as an original (generic) application; Theophylline is a bronchodilator for reversible airway o…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab [Phase 4]
Phase 4 trial update evaluating whether reducing daily ICS/LABA maintenance to an anti-inflammatory reliever approach is feasible in severe …